Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival
Authors
Keywords
-
Journal
PROSTATE
Volume 74, Issue 3, Pages 225-234
Publisher
Wiley
Online
2013-10-16
DOI
10.1002/pros.22744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies
- (2013) ANNALS OF INTERNAL MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel
- (2011) C C Uzoh et al. BRITISH JOURNAL OF CANCER
- Physical Activity and Survival After Prostate Cancer Diagnosis in the Health Professionals Follow-Up Study
- (2011) Stacey A. Kenfield et al. JOURNAL OF CLINICAL ONCOLOGY
- Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model
- (2011) Ashley Gray et al. JOURNAL OF ENDOCRINOLOGY
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
- (2011) James W Denham et al. LANCET ONCOLOGY
- Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
- (2010) J. Flanagan et al. ANNALS OF ONCOLOGY
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
- (2009) Swapnil N. Rajpathak et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Adipose tissue as an endocrine organ
- (2009) Sandra Galic et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intermittent Calorie Restriction Delays Prostate Tumor Detection and Increases Survival Time in TRAMP Mice
- (2009) Melissa J. L. Bonorden et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study
- (2008) Raina N. Fichorova et al. ANALYTICAL CHEMISTRY
- Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer
- (2008) Matthew R. Smith et al. CANCER
- Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men
- (2008) M. S. Lewitt et al. DIABETOLOGIA
- Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
- (2008) Mari-Anne Rowlands et al. INTERNATIONAL JOURNAL OF CANCER
- Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity
- (2008) Anna Kotronen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started